Jundishapur Journal of Microbiology

Published by: Kowsar

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene Polymorphisms and Hepatitis B Virus Infection

Anvar Soleimani 1 , Houshang Rafatpanah 2 , Amin Reza Nikpoor 3 , Mehrdad Kargari 4 and Daryoush Hamidi Alamdari 5 , *
Authors Information
1 Department of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Inflammation and Inflammatory Diseases Research Centre, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Department of Immunogenetic and Cell Culture, Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Department of Basic Medical Science, Neyshabur University of Medical Sciences, Neyshabur, IR Iran
5 Biochemistry and Nutrition Research Center, Department of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: November 01, 2015, 8 (11); e23578
  • Published Online: November 14, 2015
  • Article Type: Research Article
  • Received: September 25, 2014
  • Revised: February 26, 2015
  • Accepted: June 28, 2015
  • DOI: 10.5812/jjm.23578

To Cite: Soleimani A, Rafatpanah H, Nikpoor A R, Kargari M, Hamidi Alamdari D. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene Polymorphisms and Hepatitis B Virus Infection, Jundishapur J Microbiol. 2015 ; 8(11):e23578. doi: 10.5812/jjm.23578.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005; 5(3): 215-29[DOI][PubMed]
  • 2. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 2007; 85(1): 16-23[DOI][PubMed]
  • 3. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012; 142(6): 1264-1273 e1[DOI][PubMed]
  • 4. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008; 8(4): 281-94
  • 5. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 6. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008; 12(3): 378-82[DOI][PubMed]
  • 7. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995; 3(6): 673-82[PubMed]
  • 8. MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol Lett. 2003; 139(2-3): 89-97[PubMed]
  • 9. Gray HL, Sorensen EL, Hunt JS, Ober C. Three polymorphisms in the 3' UTR of the TRAIL (TNF-related apoptosis-inducing ligand) gene. Genes Immun. 2001; 2(8): 469-70[DOI][PubMed]
  • 10. Baetu TM, Hiscott J. On the TRAIL to apoptosis. Cytokine Growth Factor Rev. 2002; 13(3): 199-207[PubMed]
  • 11. Kimberley FC, Screaton GR. Following a TRAIL: update on a ligand and its five receptors. Cell Res. 2004; 14(5): 359-72[DOI][PubMed]
  • 12. Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Hum Pathol. 2005; 36(10): 1066-73[DOI][PubMed]
  • 13. Mundt B, Kuhnel F, Zender L, Paul Y, Tillmann H, Trautwein C, et al. Involvement of TRAIL and its receptors in viral hepatitis. FASEB J. 2003; 17(1): 94-6[DOI][PubMed]
  • 14. Strater J, Moller P. TRAIL and viral infection. Vitam Horm. 2004; 67: 257-74[DOI][PubMed]
  • 15. Han LH, Sun WS, Ma CH, Zhang LN, Liu SX, Zhang Q, et al. Detection of soluble TRAIL in HBV infected patients and its clinical implications. World J Gastroenterol. 2002; 8(6): 1077-80[PubMed]
  • 16. Jung YJ, Kim YJ, Kim LH, Lee SO, Park BL, Shin HD, et al. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection. Intervirology. 2007; 50(5): 369-76[DOI][PubMed]
  • 17. Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet. 2000; 58(4): 250-64[PubMed]
  • 18. Lian JQ, Yang XF, Zhao RR, Zhao YY, Li Y, Zhang Y, et al. Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection. Hepat Mon. 2014; 14(6)[DOI][PubMed]
  • 19. Kikuchi S, Miyagishi R, Fukazawa T, Yabe I, Miyazaki Y, Sasaki H. TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol. 2005; 167(1-2): 170-4[DOI][PubMed]
  • 20. Mi Y, Zhu L, Feng N. Polymorphism Analysis of TRAIL Gene and Correlation TRAIL Expression in Prostate Cancer. 2011;
  • 21. Wang C, Xu S, Yi F, Wang X, Lei Y, Huang S, et al. Tumor necrosis factor-related apoptosis inducing ligand gene polymorphisms are correlated with gastric cancer in central China. Pharm Res. 2015; 32(3): 762-8[DOI][PubMed]
  • 22. Yan X, Xu L, Qi J, Liang X, Ma C, Guo C, et al. sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics. 2009; 61(8): 551-6[DOI][PubMed]
  • 23. Yu MY, Zhao PQ, Yan XH, Liu B, Zhang QQ, Wang R, et al. Association between the TRAIL single nucleotide polymorphism rs1131580 and type 2 diabetes mellitus in a Han Chinese population. Genet Mol Res. 2013; 12(3): 3455-64[DOI][PubMed]
  • 24. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol. 2006; 87: 1439-49[DOI][PubMed]
  • 25. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003; 38(1): 4-13[DOI][PubMed]
  • 26. Ulevitch RJ, Mathison JC, da Silva Correia J. Innate immune responses during infection. Vaccine. 2004; 22 Suppl 1-30[DOI][PubMed]
  • 27. Wajant H. CD95L/FasL and TRAIL in tumour surveillance and cancer therapy. Cancer Treat Res. 2006; 130: 141-65[PubMed]
  • 28. Liang X, Liu Y, Zhang Q, Gao L, Han L, Ma C, et al. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol. 2007; 178(1): 503-10[PubMed]
  • 29. Saadatian Z, Masotti A, Nariman Saleh Fam Z, Alipoor B, Bastami M, Ghaedi H. Single-Nucleotide Polymorphisms Within MicroRNAs Sequences and Their 3' UTR Target Sites May Regulate Gene Expression in Gastrointestinal Tract Cancers. Iran Red Crescent Med J. 2014; 16(7)[DOI][PubMed]
  • 30. Motavaf M, Safari S, Alavian SM. Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: a review study. Hepat Mon. 2014; 14(7)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments